A phase IA, dose-escalating study of LBH589 administered intravenously in adult patients with advanced solid tumors

被引：0
|
作者：
Oizumi, S. [1 ]
Ando, Y. [2 ]
Kitagawa, K. [2 ]
Morita, S. [2 ]
Komatsu, Y. [3 ]
Yuki, S. [3 ]
Fujiwara, Y. [4 ,5 ]
Kiyota, N. [4 ,5 ]
Kobayashi, K. [6 ]
Minami, H. [4 ,5 ]
机构：
[1] Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido 060, Japan
[2] Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi, Japan
[3] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hematol, Sapporo, Hokkaido, Japan
[4] Kobe Univ Hosp, Kobe, Hyogo, Japan
[5] Grad Sch Med, Dept Med, Kobe, Hyogo, Japan
[6] Novartis Pharma KK, Oncol Translat Med, Tokyo, Japan
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 07期
关键词：
D O I：
10.1016/S1359-6349(10)72099-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：124 / 125
页数：2
相关论文
共 50 条
  • [1] Phase I dose-escalating study of panobinostat (LBH589) Administered intravenously to Japanese patients with advanced solid tumors
    Morita, Sachi
    Oizumi, Satoshi
    Minami, Hironobu
    Kitagawa, Koichi
    Komatsu, Yoshito
    Fujiwara, Yutaka
    Inada, Megumi
    Yuki, Satoshi
    Kiyota, Naomi
    Mitsuma, Ayako
    Sawaki, Masataka
    Tanii, Hiromi
    Kimura, Junko
    Ando, Yuichi
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (05) : 1950 - 1957
  • [2] Phase I dose-escalating study of panobinostat (LBH589) Administered intravenously to Japanese patients with advanced solid tumors
    Sachi Morita
    Satoshi Oizumi
    Hironobu Minami
    Koichi Kitagawa
    Yoshito Komatsu
    Yutaka Fujiwara
    Megumi Inada
    Satoshi Yuki
    Naomi Kiyota
    Ayako Mitsuma
    Masataka Sawaki
    Hiromi Tanii
    Junko Kimura
    Yuichi Ando
    Investigational New Drugs, 2012, 30 : 1950 - 1957
  • [3] A phase I study of oral panobinostat (LBH589) in Japanese patients with advanced solid tumors
    Fukutomi, Akira
    Hatake, Kiyohiko
    Matsui, Kaoru
    Sakajiri, Sakura
    Hirashima, Tomonori
    Tanii, Hiromi
    Kobayashi, Ken
    Yamamoto, Nobuyuki
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (03) : 1096 - 1106
  • [4] A phase I study of oral panobinostat (LBH589) in Japanese patients with advanced solid tumors
    Akira Fukutomi
    Kiyohiko Hatake
    Kaoru Matsui
    Sakura Sakajiri
    Tomonori Hirashima
    Hiromi Tanii
    Ken Kobayashi
    Nobuyuki Yamamoto
    Investigational New Drugs, 2012, 30 : 1096 - 1106
  • [5] A phase I study of oral panobinostat (LBH589) in Japanese patients with advanced solid tumours
    Okamoto, N.
    Hatake, K.
    Yamamoto, N.
    Takahashi, S.
    Boku, N.
    Kobayashi, K.
    Sakatani, K.
    Hirashima, T.
    Matsui, K.
    EJC SUPPLEMENTS, 2008, 6 (12): : 133 - 133
  • [6] Phase IA/II study of oral LBH589, a novel deacetylase inhibitor (DACi), administered on 2 schedules, in patients with advanced hematologic malignancies
    Spencer, Andrew
    Prince, Miles
    DeAngelo, Daniel J.
    Fischer, Thomas
    Bhalla, Kapil N.
    Giles, Francis J.
    Liu, Angela
    Parker, Kathryn
    Laird, Glen
    Masson, Eric
    Rediske, John
    Scott, Jeffrey W.
    Ottmann, Oliver G.
    BLOOD, 2007, 110 (11) : 276A - 277A
  • [7] PHASE 1 DOSE-ESCALATING STUDY OF BMS-754807 IN JAPANESE PATIENTS WITH ADVANCED SOLID TUMORS
    Tamura, Y.
    Nokihara, H.
    Yamamoto, N.
    Wakui, H.
    Honda, K.
    Asahina, H.
    Yamada, Y.
    Komaba, T.
    Tamura, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 111 - 112
  • [8] A Phase II Study of Oral Panobinostat (LBH589) in Adult Patients with Advanced Refractory Multiple Myeloma.
    Wolf, Jeffrey Lee
    Siegel, David
    Matous, Jeffrey
    Lonial, Sagar
    Goldschmidt, Hartmut
    Schmitt, Stefan
    Vij, Ravi
    De Malgalhaes-Silverman, Margarida
    Abonour, Rafat
    Jalaluddin, Muhammad
    Li, Martha
    Hazell, Katharine
    Bourquelot, Priscille M.
    Mateos, Maria-Victoria
    Anderson, Kenneth C.
    Spencer, Andrew
    Harousseau, Jean-Luc
    Blade, Joan
    BLOOD, 2008, 112 (11) : 957 - 957
  • [9] Phase I dose-escalating study of biweekly fixed-dose rate gemcitabine plus pemetrexed in patients with advanced solid tumors
    Yuan, Yuan
    Cohen, Deirdre J.
    Love, Erica
    Yaw, Michelle
    Levinson, Benjamin
    Nicol, Steven J.
    Hochster, Howard S.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (02) : 371 - 378
  • [10] Phase I dose-escalating study of biweekly fixed-dose rate gemcitabine plus pemetrexed in patients with advanced solid tumors
    Yuan Yuan
    Deirdre J. Cohen
    Erica Love
    Michelle Yaw
    Benjamin Levinson
    Steven J. Nicol
    Howard S. Hochster
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 371 - 378
12345